Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept cookies
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • Federal Reserve shifts to quarter-point rate rise but warns of more to come
    • Battle of Bakhmut nears tipping point as Russia intensifies offensive
    • Economists detect dovish undertones from ‘more optimistic’ Jay Powell
    • Military briefing: does Ukraine need western fighter jets?
    • ECB set to raise rates despite fall in eurozone inflation
  • UK
    Sections
    • UK Home
    • UK Business & Economy
    • UK Politics & Policy
    • Brexit
    • UK Companies
    • Personal Finance
    Most Read
    • NatWest boss refuses to attend parliamentary hearing
    • Bank of England raises interest rates by 0.5 percentage points to 4%
    • Flat owners win Supreme Court Tate Modern privacy case
    • Register of UK property held offshore lists 40 owners under sanctions
    • Is the IMF right about the UK economy?
  • Companies
    Sections
    • Companies Home
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
    Most Read
    • Adani Enterprises calls off $2.4bn share sale
    • Gautam Adani defends ‘robust’ business as stock losses reach $100bn
    • New York property tycoon to give worn-out offices ‘back to the bank’
    • Goldman to fund meagre payouts to banks hammered by Archegos collapse
    • ‘Extreme leverage’? Adani’s debt-driven expansion under scrutiny
  • Tech
  • Markets
    Sections
    • Markets Home
    • Alphaville
    • Markets Data
    • Cryptofinance
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
    Most Read
    • Adani Enterprises calls off $2.4bn share sale
    • Live news updates from February 1: Fed lifts rates 0.25 points, Eurozone inflation slows sharply
    • Interest rates live: Euro slips against dollar after ECB raises key rate to 2.5%
    • US stocks jump after Fed announces smaller rate rise
    • Shell profits more than double to record $40bn
  • Climate
  • Opinion
    Sections
    • Opinion Home
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
    Most Read
    • The return of the ‘British disease’
    • Beware the great battery industry fallacy
    • End the Fed ‘put’
    • Conservatives are forced to face the economic case for net zero
    • The corporate world is losing its grip on cyber risk
  • Work & Careers
    Sections
    • Work & Careers Home
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    Most Read
    • Shoshana Zuboff: ‘Privacy has been extinguished. It is now a zombie’
    • A new generation refuses to keep quiet on age discrimination at work
  • Life & Arts
    Sections
    • Life & Arts Home
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
    Most Read
    • Alexa Chung on the unpolished appeal of Indie Sleaze
    • Retiring at 62? The French have it absolutely right
    • The secrets of the Mercedes-Benz Holy Halls
    • Why I’m only buying five new things in 2023
    • What a perilous flight from North Korea tells us about digital connections
  • HTSI
MenuSearch
  • Home
  • World
  • UK
  • Companies
  • Tech
  • Markets
  • Climate
  • Opinion
  • Work & Careers
  • Life & Arts
  • HTSI
Financial Times
SubscribeSign In

Medical science

Add to myFT Digest

Add this topic to your myFT Digest for news straight to your inbox

  • Sunday, 29 January, 2023
    Drugs research
    RQ Bio partners with AstraZeneca in Covid antibody fight

    UK biotech racing to keep antibody up to date with latest variants

  • Tuesday, 24 January, 2023
    Kate Bingham
    Britain is losing its chance to become a life sciences superpower

    Short-termism and suspicion in parts of government risk our valuable future in precision medicine

  • Tuesday, 17 January, 2023
    InterviewJenny Harries
    Covid will ‘taunt us’ for years, says UK health security chief

    Future of pandemic less predictable than at the outset because of new variants, says Jenny Harries

  • Wednesday, 11 January, 2023
    Anjana Ahuja
    New Alzheimer’s drug straddles uneasy gulf between help and harm

    For all its landmark status, lecanemab may end up representing a triumph of hope over evidence

  • Tuesday, 10 January, 2023
    Coronavirus pandemic
    China suspends travel visas from Japan and S Korea over Covid curbs

    Beijing accuses countries of ‘political manipulation’ for introducing testing requirements during exit wave

  • Monday, 9 January, 2023
    Disrupted Times
    World awaits return of Chinese tourists

    Also in this edition: eurozone unemployment falls to new low, uproar in Brazil and Rolls-Royce hits sales record

  • Sunday, 8 January, 2023
    Alphabet’s Verily seeks to eradicate dengue in Singapore

    Bid to extend tech throughout city state to wipe out disease-carrying mosquito population

  • Friday, 6 January, 2023
    UK signs deal with BioNTech for cutting-edge cancer trials

    Covid-19 vaccine maker hails ‘huge’ investment aimed at recruiting 10,000 participants with NHS

  • Thursday, 5 January, 2023
    ExplainerCoronavirus pandemic
    How serious is the threat of new Covid-19 variants?

    A surge in cases after China lifted restrictions has sparked concerns that a dangerous new strain could emerge

  • Thursday, 5 January, 2023
    The Big Read
    The UK’s dream of becoming a ‘science superpower’

    Ministers want to supercharge the £89bn life science industry. But it will take long-term thinking on investment, talent and infrastructure

  • Wednesday, 4 January, 2023
    Coronavirus pandemic
    China has under-represented its number of Covid deaths, says WHO

    Global health body issues its strongest rebuke yet of Beijing’s handling of the pandemic

  • Wednesday, 4 January, 2023
    Anjana Ahuja
    We may be entering Covid’s least predictable year yet

    China’s unleashing of the virus is raising questions about the potential for harmful, new variants

  • Tuesday, 3 January, 2023
    LexChinese business & finance
    China banks: Covid will eclipse property woe this new year Premium content

    Chinese authorities will expect big banks to support struggling enterprises with soft loans and outright rescues

  • Tuesday, 3 January, 2023
    The Big Read
    China’s Covid generation: the surging inequality behind Xi’s U-turn

    Lockdowns have often been more relentless in rural areas, upending the education of millions and blocking social mobility

  • Monday, 2 January, 2023
    LexDrugs research
    Moderna/BioNTech: cancer vaccines will show mRNA not a one-trick pony Premium content

    Success in battle against Covid does not ensure success against tumours, but should narrow the odds

  • Sunday, 1 January, 2023
    News in-depthChinese politics & policy
    Xi’s credibility ‘badly wounded’ as China’s Covid death toll mounts

    Beijing’s war games with Russia and aggression against Taiwan fail to distract from public health crisis

  • Friday, 30 December, 2022
    Genomics
    UK to embark on groundbreaking new genomics projects

    Programmes involving millions of volunteers will cement Britain’s place as leader in DNA research

  • Thursday, 29 December, 2022
    Coronavirus pandemic
    UK weighs Covid restrictions for travellers from China

    Move comes as US, Japan and India introduce tests and EU debates issue with Italy

  • Thursday, 29 December, 2022
    Coronavirus pandemic
    EU rejects Italian demand to impose Covid curbs on arrivals from China

    France, Germany and other states say situation does not warrant change in coronavirus policies

  • Thursday, 29 December, 2022
    The FT ViewThe editorial board
    World must be vigilant amid China’s Covid reopening

    There are echoes of early 2020 in Xi’s policy of obfuscation

  • Wednesday, 28 December, 2022
    Hong Kong
    Hong Kong abandons last Covid curbs to revive economy

    Territory drops mandatory testing for arrivals as it follows Beijing’s exit from virus controls

  • Wednesday, 28 December, 2022
    OutlookJoe Leahy
    Exit from zero-Covid is no easy path for China

    Forced to abandon its draconian policy, Beijing’s unconvincing narrative cannot hide its lack of preparation

  • Wednesday, 28 December, 2022
    News in-depthDrugs research
    Race is on to develop new generation of weight-loss drugs

    Eli Lilly, Amgen, Pfizer and Regeneron follow Novo Nordisk into obesity treatments worth billions

  • Tuesday, 27 December, 2022
    Chinese politics & policy
    China scraps inbound quarantine rules in decisive break with zero-Covid

    Requirement of five days at a hotel followed by three days at home will end on January 8

  • Tuesday, 27 December, 2022
    News in-depthCoronavirus pandemic
    ‘Made of flesh, not iron’: China’s medics battle zero-Covid exit wave

    Doctors and nurses given ‘no choice’ but to work while infected after influx of cases inundates hospitals

Previous page You are on page 1 Next page

Useful links

Support

View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

Legal & Privacy

Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

Services

Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT ChannelsSecondary Schools

Tools

PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

Community & Events

FT CommunityFT Live EventsFT ForumsFT Board DirectorBoard Director Programme

More from the FT Group

Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2023. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Financial Times

UK Edition

Subscribe for full access
  • Switch to International Edition
  • Top sections
  • Home
  • World
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
  • UK
    • UK Business & Economy
    • UK Politics & Policy
    • Brexit
    • UK Companies
    • Personal Finance
  • Companies
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
  • Tech
  • Markets
    • Alphaville
    • Markets Data
    • Cryptofinance
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
  • Climate
  • Opinion
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
  • Work & Careers
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
  • Life & Arts
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
  • Personal Finance
    • Property & Mortgages
    • Investments
    • Pensions
    • Tax
    • Banking & Savings
    • Advice & Comment
    • Next Act
  • HTSI
  • Special Reports
  • FT recommends
  • Lex
  • Alphaville
  • Lunch with the FT
  • FT Globetrotter
  • #techAsia
  • Moral Money
  • FTfm
  • Newsletters
  • Video
  • Podcasts
  • News feed
  • FT Live Events
  • FT Forums
  • Board Director Programme
  • myFT
  • Portfolio
  • Today's Newspaper (ePaper)
  • Crossword
  • Our Apps
  • Help Centre
  • Subscribe
  • Sign In